Novel treatment (new drug/intervention; established drug/procedure in new situation): Novel antibiotic regime for pseudomonal scleritis complicating scleral buckling surgery

doi:10.1136/bcr.01.2009.1514

BMJ Case Rep. 2010; 2010: bcr01.2009.1514.

Published online 2010 April 29. doi: 10.1136/bcr.01.2009.1514

PMCID: PMC3047173

Novel treatment (new drug/intervention; established drug/procedure in new situation)

Novel antibiotic regime for pseudomonal scleritis complicating scleral buckling surgery

Deric De Wit and Douglas Newman

Addenbrookes Hospital, Ophthalmology, Hills Rd, Cambridge, CB2 2QQ, UK

Correspondence to Deric De Wit, Email: dewitd/at/doctors.org.uk

Abstract

Pseudomonal scleritis complicating scleral buckling surgery is described in a patient unable to tolerate systemic side effects from aminoglycoside antibiotics. Particular reference is made to a novel antibiotic regimen comprising systemic ceftazidine and ciprofloxacin.

Articles from BMJ Case Reports are provided here courtesy of
BMJ Group